Esomeprazole and omeprazole could improve the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about improved adverse effects which include drowsiness, although the clinical relevance is minimal in the majority of clients – observe the patient for adverse effects (e. If affected individual can't resume their standard oral medication article-operatively https://medeusresearchchem.com/product-category/research-chemicals/